Skip to main content

anti-cd33/bet degrader adc abbv-787

Generic: Anti-CD33/BET Degrader ADC ABBV-787

anti-cd33/bet degrader adc abbv-787: 1 clinical trial tracked.

anti-cd33/bet degrader adc abbv-787 evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about anti-cd33/bet degrader adc abbv-787, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (1)

Expanded Access to ABBV-787

NCT06439966Registry updated 2026-02-12·N/A·ABBV
No longer available
Expanded AccessAbbVie